Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia

Familial hypercholesterolemia (FH) is an inherited disorder. The level of low-density lipoprotein cholesterol (LDL-C) in patients with homozygous FH can be twice as high as that in patients with heterozygous FH. The inhibition of ANGPTL3 shows an important therapeutic approach in reducing LDL-C and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosnowska, Bożena, Adach, Weronika, Surma, Stanisław, Rosenson, Robert S., Banach, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821629/
https://www.ncbi.nlm.nih.gov/pubmed/36614969
http://dx.doi.org/10.3390/jcm12010168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821629/
https://www.ncbi.nlm.nih.gov/pubmed/36614969
http://dx.doi.org/10.3390/jcm12010168

Ejemplares similares